In addition, the induction of mucosal IgA response, which was variably induced by SARS-CoV-2 mRNA vaccines, was shown to be associated with protection against subsequent infection, suggesting that COVID-19 vaccines that elicit a durable IgA response may have utility in preventing infection [26]. The gene discussed is CD79A; the disease is COVID-19.